Marco Oderda Selected Research

Androgens

1/2022	The SAFE Pilot Trial-SAlvage Focal Irreversible Electroporation-For Recurrent Localized Prostate Cancer: Rationale and Study Protocol.
10/2021	Risk of cardiovascular toxicities and hypertension in nonmetastatic castration-resistant prostate cancer patients treated with novel hormonal agents: a systematic review and meta-analysis.
8/2015	A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco Oderda Research Topics

Disease

26	Prostatic Neoplasms (Prostate Cancer) 12/2022 - 12/2010
12	Neoplasms (Cancer) 07/2022 - 01/2015
6	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 05/2009
4	Non-Muscle Invasive Bladder Neoplasms 12/2017 - 03/2010
3	Kidney Neoplasms (Kidney Cancer) 01/2022 - 10/2013
3	Pain (Aches) 12/2020 - 04/2015
3	Pathologic Constriction (Stenosis) 10/2019 - 01/2017
2	Neoplasm Metastasis (Metastasis) 05/2022 - 01/2018
2	Penile Induration (Peyronie's Disease) 01/2018 - 05/2016
2	Infections 12/2017 - 05/2016
2	Erectile Dysfunction 05/2016 - 07/2015
1	Obesity 05/2022
1	Anemia 03/2022
1	Testicular Neoplasms (Testicular Cancer) 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Drug-Related Side Effects and Adverse Reactions 01/2022
1	Hypertension (High Blood Pressure) 10/2021
1	COVID-19 06/2021
1	Extranodal Extension 01/2021
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2020
1	Atherosclerosis 01/2020
1	Heart Failure 01/2020
1	Myocardial Infarction 01/2020
1	Hypothermia 08/2019
1	Hematoma 01/2018
1	Fistula 08/2017
1	Intraoperative Complications 01/2017
1	Cysts 10/2016
1	Hemorrhage 05/2016
1	Ejaculatory Dysfunction 01/2016
1	Prostatic Intraepithelial Neoplasia 08/2015
1	Pudendal Neuralgia 04/2015
1	Disease Progression 08/2013

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2018
4	Hormones (Hormone)IBA 05/2022 - 09/2012
3	AntigensIBA 05/2022 - 07/2021
3	AndrogensIBA 01/2022 - 08/2015
3	MicroRNAs (MicroRNA)IBA 01/2019 - 08/2015
3	Prostate-Specific Antigen (Semenogelase)IBA 01/2019 - 09/2012
2	gallium 68 PSMA-11IBA 05/2022 - 11/2020
2	enzalutamideIBA 01/2022 - 10/2021
2	apalutamideIBA 01/2022 - 10/2021
2	darolutamideIBA 01/2022 - 10/2021
1	Capsules (Microcapsules)IBA 07/2022
1	A 7 (A-7)IBA 05/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 03/2022
1	Androgen Receptors (Androgen Receptor)IBA 01/2022
1	Androgen Antagonists (Antiandrogens)IBA 01/2021
1	Small Untranslated RNAIBA 06/2020
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2020
1	CytokinesIBA 08/2019
1	GasesIBA 08/2019
1	Interleukin-6 (Interleukin 6)IBA 08/2019
1	ImmunosorbentsIBA 10/2018
1	EnzymesIBA 10/2018
1	Proteins (Proteins, Gene)FDA Link 10/2018
1	Metalloproteases (Metalloproteinases)IBA 10/2018
1	FluoroquinolonesIBA 12/2017
1	Adhesives (Glues)IBA 08/2017
1	IfabondIBA 08/2017
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 11/2016
1	propylene diquat (PDQ(+))IBA 05/2016
1	ThuliumIBA 01/2016
1	HolmiumIBA 01/2016
1	AntioxidantsIBA 08/2015
1	SeleniumIBA 08/2015
1	TeaIBA 08/2015
1	Vitamin E FDA LinkGeneric 08/2015
1	LycopeneIBA 08/2015
1	Pharmaceutical PreparationsIBA 04/2015
1	Dihydrotachysterol (AT 10)IBA 01/2015
1	Gemcitabine FDA Link 09/2013
1	Finasteride (Propecia)FDA LinkGeneric 12/2010

Therapy/Procedure

13	Prostatectomy (Retropubic Prostatectomy) 12/2022 - 09/2012
9	Therapeutics 10/2022 - 01/2011
4	Castration 03/2022 - 01/2021
3	Nephrectomy 01/2022 - 10/2013
3	Length of Stay 10/2019 - 01/2017
3	Operative Time 01/2018 - 08/2013
3	Drug Therapy (Chemotherapy) 09/2013 - 03/2010
2	Cystectomy 01/2022 - 05/2009
2	Local Anesthesia 01/2022 - 12/2020
2	Salvage Therapy 01/2022 - 11/2020
1	Pneumonectomy (Lung Volume Reduction) 05/2022
1	Drug Tapering 03/2022
1	Nephroureterectomy 01/2022
1	Lymph Node Excision (Lymph Node Dissection) 01/2021
1	Radiotherapy 08/2019
1	Stents 05/2018
1	Penile Implantation 01/2018
1	Intravesical Administration 12/2017
1	Immunotherapy 12/2017
1	Blood Transfusion (Blood Transfusions) 05/2016
1	Contraindications 02/2016
1	Electrosurgery 01/2016
1	Lasers (Laser) 01/2016
1	Chemoprevention 08/2015
1	Surgical Amputation (Amputations) 07/2015
1	Decompression 04/2015